Mechanisms of Notch1 in Aortic Valve Calcification
Mechanisms of Notch1 in Aortic Valve Calcification
批准号:
7812206
负责人:
VISHAL NIGAM
金额:
$13.02万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-08-15 至 2012-04-30
关键词:
AdultAgeAortic Valve StenosisApoptosisBicuspidBlood VesselsCalcifiedCalciumCardiacCardiovascular systemCell Differentiation processCellsComputer Systems DevelopmentDataDepositionDeveloped CountriesDiseaseEventFamilyFamily memberGenderGene ExpressionGenesHeartHeart DiseasesHumanHyperlipidemiaHypertensionImmune systemIn VitroIncidenceInfiltrationInflammatoryKnockout MiceLaboratoriesLinkLipidsLipoproteinsMediatingMesenchymalMesenchymeMolecularMusMutationMyofibroblastNOTCH1 geneOsteoblastsOsteogenesisPathologicPathway interactionsPatternPlayPregnancyReportingRepressionResearch PersonnelRisk FactorsRoleSignal PathwaySignal TransductionSmokingStenosisStressTissuesWorkabstractingaortic valvecalcificationhemodynamicsmacrophagemalemalformationmouse modelnotch proteinosteogenicprogramsrelating to nervous systemresponseshear stressvascular bed
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant):
Aortic valve calcification/stenosis is the third leading cause of adult heart disease and the most common form of acquired valvular disease in developed countries. The risk factors most closely linked to calcific aortic stenosis are the presence of a bicuspid aortic valve, increased age, male gender, smoking, hypertension, and elevated lipoproteins. Examination of human calcified aortic valve tissue has shown that several pathologic pathways are involved. However, the molecular mechanisms involved in valvular calcification have not been elucidated. Recently, the Srivastava lab reported two human families in which mutations in NOTCH1 were associated with early calcification of the aortic valve and bicuspid aortic valves. Notchl is a part of a highly conserved signaling pathway involved in many cellular events, including cell fate decisions and cell differentiation. This study demonstrated that Hrt2, a transcriptional represser that mediates the Notchl signal, could regulate the activity of Runx2, a central regulator of osteoblast cell fate determination in vitro. Our preliminary data show that Notchl heterozygous mice develop increased aortic valve calcification as compared to wild-type age matched littermates. I hypothesize that Notchl signaling represses pro-osteogenic pathways in aortic valve mesenchyme and that Notchl disruption may sensitize the valve to known risk factors that promote calcification. Specific Aim 1: To determine if disrupting Notchl signaling causes calcification of the aortic valve by activation of osteogenic pathways in mice. Notchl signaling will be conditionally disrupted in aortic valve tissue valves prenatally or postnatally. The aortic valves will be examined for functional stenosis, calcification, and expression of genes involved in bone formation. In addition, Notchl-deficient mice will be crossed with a mouse model of hyperlipidemia to examine the contribution of this risk factor to Notchl-mediated aortic valve calcification. Specific Aim 2: To elucidate the calcific pathways mediated by Notchl in mesenchymal and endocardial cells. Notchl expression will be disrupted or enhanced in cultured mesenchymal and endocardial cells under various conditions. Mesenchymal cells will be examined for activation or repression of osteoblast-specific gene expression and in some cases deposition of calcium. The interactions between Notchl signaling and three molecular pathways previously implicated in cardiovascular calcification, namely Runx2, Bmp2, and Wnt, will be examined.
(End of Abstract)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Supraphysiologic Shear Stresses Associated with Cardiopulmonary Bypass are Sufficient to Activate RIKP3 Signaling
-
批准号:10606640
-
项目类别:
-
资助金额:$80.16万
-
财政年份:2022
-
负责人:VISHAL NIGAM
-
依托单位:
Supraphysiologic Shear Stresses Associated with Cardiopulmonary Bypass are Sufficient to Activate RIKP3 Signaling
-
批准号:10446535
-
项目类别:
-
资助金额:$82.98万
-
财政年份:2022
-
负责人:VISHAL NIGAM
-
依托单位:
A Multiscale Modeling Approach to Hypoplastic Left Heart Syndrome
-
批准号:9053027
-
项目类别:
-
资助金额:$38.24万
-
财政年份:2016
-
负责人:VISHAL NIGAM
-
依托单位:
A Multiscale Modeling Approach to Hypoplastic Left Heart Syndrome
-
批准号:9260047
-
项目类别:
-
资助金额:$37.55万
-
财政年份:2016
-
负责人:VISHAL NIGAM
-
依托单位:
A Multiscale Modeling Approach to Hypoplastic Left Heart Syndrome
-
批准号:9766412
-
项目类别:
-
资助金额:$36.43万
-
财政年份:2016
-
负责人:VISHAL NIGAM
-
依托单位:
Mechanisms of Notch1 in Aortic Valve Calcification
-
批准号:7561331
-
项目类别:
-
资助金额:$13.02万
-
财政年份:2007
-
负责人:VISHAL NIGAM
-
依托单位:
Mechanisms of Notch1 in Aortic Valve Calcification
-
批准号:7483691
-
项目类别:
-
资助金额:$13.02万
-
财政年份:2007
-
负责人:VISHAL NIGAM
-
依托单位:
Mechanisms of Notch1 in Aortic Valve Calcification
-
批准号:8096600
-
项目类别:
-
资助金额:$13.02万
-
财政年份:2007
-
负责人:VISHAL NIGAM
-
依托单位:
Mechanisms of Notch1 in Aortic Valve Calcification
-
批准号:7616412
-
项目类别:
-
资助金额:$13.02万
-
财政年份:2007
-
负责人:VISHAL NIGAM
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: